about
Autonomic neuropathy in diabetes mellitusNatural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a TargetHistone Acetylation and Its Modifiers in the Pathogenesis of Diabetic NephropathyOxytocin and cardioprotection in diabetes and obesityGenetics of cardiovascular and renal complications in diabetesDrug Targets for Oxidative Podocyte Injury in Diabetic NephropathyDiabetic Cardiovascular Disease Induced by Oxidative StressMagnesium in Prevention and TherapyThe Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and AutoimmunityNew insights from monogenic diabetes for "common" type 2 diabetesBedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment CriteriaBeat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agentsToxic stress, inflammation and symptomatology of chronic complications in diabetesDiabetic kidney disease: from physiology to therapeuticsVascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathyCurrent status of managing diabetes mellitus in KoreaThe Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetesIdentifying and Describing the Impact of Cyclone, Storm and Flood Related Disasters on Treatment Management, Care and Exacerbations of Non-communicable Diseases and the Implications for Public HealthStabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathyEdaravone protected human brain microvascular endothelial cells from methylglyoxal-induced injury by inhibiting AGEs/RAGE/oxidative stressC3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathwayAngiotensin type 1 receptor mediates renal production and conversion of prostaglandins E2 to F2α in conscious diabetic ratsClinical therapeutic strategies for early stage of diabetic kidney disease.Refractive index tomograms and dynamic membrane fluctuations of red blood cells from patients with diabetes mellitus.Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets.Skeletal Muscle Nucleo-Mitochondrial Crosstalk in Obesity and Type 2 Diabetes.Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.Hepatoprotective, Antihyperlipidemic, and Anti-inflammatory Activity of Moringa oleifera in Diabetic-induced Damage in Male Wistar RatsJiangtang decoction ameliorate diabetic nephropathy through the regulation of PI3K/Akt-mediated NF-κB pathways in KK-Ay miceMesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.Long-lasting effect of obesity on skeletal muscle transcriptome.Xenotransplantation - A special case of One HealthTanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation.Effect of Nigella sativa fixed and essential oils on antioxidant status, hepatic enzymes, and immunity in streptozotocin induced diabetes mellitus.Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress.Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus.A Perspective on Reagent Diversity and Non-covalent Binding of Reactive Carbonyl Species (RCS) and Effector Reagents in Non-enzymatic Glycation (NEG): Mechanistic Considerations and Implications for Future Research.A cross-sectional study on the associations of insulin resistance with sex hormone, abnormal lipid metabolism in T2DM and IGT patients.
P2860
Q21131270-E6750D41-D0CB-4F35-BC6A-4BAFF4224EC9Q26741391-E0CC4894-451C-4921-ADF9-97BFAF83C6C8Q26744442-95C9F44D-A3C3-472B-A815-4874F599C9BAQ26748592-51D08DEC-375A-44E8-AC8E-35A4A2CEC1DAQ26752749-5A9097A0-B30F-4DD1-8BF3-445ACE85BC86Q26769787-02692945-27B0-43AA-B6D7-838659455E38Q26778017-555120DB-464A-42A7-936D-7CAA2A7FC0EAQ26781293-455CA4B0-DFBC-4EB3-8491-E874C22581DCQ26785900-82867B09-650A-4BD7-BBAD-DE203A3C1736Q26795455-DC75D8AA-C09C-405E-8288-50703E8F34AAQ26797153-DA7D210E-11A9-4053-A8A6-BD44BE10A739Q27010669-5675C51B-E7AE-48EB-8139-30A9713797D6Q27011633-2C937EFE-7856-433D-BB47-FD644B1E411EQ27021392-F00DB076-62DE-4C8E-96A8-CC8E867131C4Q27342809-1D79CF5E-6077-4E3D-BBC3-3AF18557F311Q28069723-D065FD11-6F52-4076-8A07-B66B836B5F09Q28075888-9ED83F44-7FEC-49B5-82E4-8DE2BD0FF9E9Q28081462-ECF64F99-8C9C-469E-9F85-E10445D8BF5DQ28390363-5140F4AA-79FC-411F-B20D-546024B78C2FQ28391260-C7658093-88B3-4058-82AF-3FABF6114068Q28533889-E2DFF597-0746-42B9-8654-5909DD1A1459Q28545168-72EC1E7B-125C-4570-9F0E-0D7104000752Q30278978-D3A2DD7F-96B0-4BF4-B02B-A2BB3142B269Q30363683-2CAA6BC3-ED28-4453-9DFF-4F37251A0BAFQ30850527-6A35279C-2B65-4136-8384-8A3B8A9CCE7DQ31154570-7620E0F3-BF1B-4E94-A62F-83FACB047D0FQ33614346-BAD533B0-5163-4885-A885-6DD778BF5A85Q33624769-A3D4C920-17AC-4F0C-80E5-01C5581A532CQ33633674-3B03125E-E11A-4469-9618-57E5701C85CDQ33655699-E1DE5DEA-1BFD-4AFB-ADE2-A8417EC1A239Q33706208-927F417F-36F5-493B-A272-9D44E1D5DF9BQ33719419-6B49E6E2-AF92-4D1B-BA08-DF032FA3ACDFQ33729970-6DD30FF1-55E5-4B11-B3BC-D7C6892E76E8Q33753481-F2B4ADDB-EBE2-4C4D-9DB8-589A6E433FC1Q33761954-6BEAE63A-2975-4D8B-9654-8EE046F34C68Q33829096-9024741D-0D59-4000-BAED-2E45A8E0DBDDQ33849720-38350B9B-CF33-45AD-BA2A-F3D1CDEB40B7Q33854354-F4D2DCCB-A372-40B5-B859-7A1DF2D34425Q33854460-81878CCB-16B5-4F7A-BCF6-4EF1678EF68FQ33879884-C634AA60-D183-41E2-962F-869EACB7E771
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mechanisms of diabetic complications.
@en
type
label
Mechanisms of diabetic complications.
@en
prefLabel
Mechanisms of diabetic complications.
@en
P1476
Mechanisms of diabetic complications
@en
P2093
Mark E Cooper
P304
P356
10.1152/PHYSREV.00045.2011
P577
2013-01-01T00:00:00Z